Estrella Immunopharma, Inc. (ESLA) vs Evaxion A/S - Sponsored ADR (EVAX)

Estrella Immunopharma, Inc. and Evaxion A/S - Sponsored ADR are both Biotechnology companies. Estrella Immunopharma, Inc. and Evaxion A/S - Sponsored ADR are of similar size ($23.4M and $23.3M). Across the 9 metrics below, Estrella Immunopharma, Inc. leads on 5 and Evaxion A/S - Sponsored ADR on 4.

Valuation

Metric ESLA EVAX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.97 9.71
P/B n/m 2.21 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 1.30 9.21
Earnings yield (56.72%) (34.28%) (33.15%)
Free cash flow yield (50.75%) (145.38%) (25.50%)

Profitability

Metric ESLA EVAX Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 148.05% (96.10%) (56.36%)
Return on assets (416.74%) (36.20%) (48.04%)
Return on invested capital 0.00% (245.79%) 0.00%

Growth

Metric ESLA EVAX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (188.78%) 89.85% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ESLA EVAX Biotechnology median
Debt to equity 0.00 0.71 0.00
Current ratio 0.20 5.06 4.72
Net debt to EBITDA 0.11 1.87 0.96

Dividend

Metric ESLA EVAX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ESLA EVAX Biotechnology median
Market cap 23.28m 23.35m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack